MYC and lymphoma: As shown in Figure 2A, analysis of cfDNA levels across LBCL subtypes showed that they were particularly elevated in patients with high-grade lymphoma with rearrangement of MYC and BCL2 (median 518 ng/mL) in comparison with patients with other LBCL subtypes (p < 0.001).